232 related articles for article (PubMed ID: 22510463)
1. Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia.
Sharma B; Singh N
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):207-15. PubMed ID: 22510463
[TBL] [Abstract][Full Text] [Related]
2. Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.
Sharma B; Singh N
Psychopharmacology (Berl); 2012 Oct; 223(3):307-17. PubMed ID: 22526544
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological investigations on potential of peroxisome proliferator-activated receptor-gamma agonists in hyperhomocysteinemia-induced vascular dementia in rats.
Sain H; Sharma B; Jaggi AS; Singh N
Neuroscience; 2011 Sep; 192():322-33. PubMed ID: 21777659
[TBL] [Abstract][Full Text] [Related]
4. Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors.
Sharma B; Sharma PM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):180-8. PubMed ID: 23921152
[TBL] [Abstract][Full Text] [Related]
5. Effects of fisetin on hyperhomocysteinemia-induced experimental endothelial dysfunction and vascular dementia.
Hemanth Kumar B; Arun Reddy R; Mahesh Kumar J; Dinesh Kumar B; Diwan PV
Can J Physiol Pharmacol; 2017 Jan; 95(1):32-42. PubMed ID: 27901381
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease.
Gupta S; Sharma B
Brain Res Bull; 2014 Mar; 102():57-68. PubMed ID: 24582883
[TBL] [Abstract][Full Text] [Related]
7. Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and neurotoxicity in Wistar rats.
Hemanth Kumar B; Dinesh Kumar B; Diwan PV
Pharm Biol; 2017 Dec; 55(1):146-155. PubMed ID: 27677544
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats.
Sharma B; Singh N
Pharmacol Biochem Behav; 2013 Feb; 103(4):821-30. PubMed ID: 23201648
[TBL] [Abstract][Full Text] [Related]
9. Possible role of endothelin receptor against hyperhomocysteinemia and β-amyloid induced AD type of vascular dementia in rats.
Singh M; Prakash A
Brain Res Bull; 2017 Jul; 133():31-41. PubMed ID: 28274813
[TBL] [Abstract][Full Text] [Related]
10. Experimental hypertension induced vascular dementia: pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor.
Sharma B; Singh N
Pharmacol Biochem Behav; 2012 Jul; 102(1):101-8. PubMed ID: 22507914
[TBL] [Abstract][Full Text] [Related]
11. Ocimum Sanctum Linn: A Potential Adjunct Therapy for Hyperhomocysteinemia-Induced Vascular Dementia.
Pasangulapati JP; Ravula AR; Kanala DR; Boyina S; Gangarapu K; Boyina HK
Adv Exp Med Biol; 2020; 1195():213-225. PubMed ID: 32468480
[TBL] [Abstract][Full Text] [Related]
12. Ameliorative effect of ozagrel, a thromboxane A2 synthase inhibitor, in hyperhomocysteinemia-induced experimental vascular cognitive impairment and dementia.
Bhatia P; Singh N
Fundam Clin Pharmacol; 2021 Aug; 35(4):650-666. PubMed ID: 33020931
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats.
Sharma B; Singh N
Pharmacol Biochem Behav; 2011 Dec; 100(2):320-9. PubMed ID: 21893084
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia.
Kumar A; Kumar A; Jaggi AS; Singh N
Pharmacol Biochem Behav; 2015 Aug; 135():20-30. PubMed ID: 25987325
[TBL] [Abstract][Full Text] [Related]
15. Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia.
Bhatia P; Singh N
Int J Neurosci; 2022 Apr; 132(4):384-396. PubMed ID: 32859137
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
Singh G; Sharma B; Jaggi AS; Singh N
Pharmacol Biochem Behav; 2014 Sep; 124():27-35. PubMed ID: 24836182
[TBL] [Abstract][Full Text] [Related]
17. Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes.
Sharma B; Singh N
Curr Neurovasc Res; 2010 Aug; 7(3):180-91. PubMed ID: 20560881
[TBL] [Abstract][Full Text] [Related]
18. Ozagrel a thromboxane A2 synthase inhibitor extenuates endothelial dysfunction, oxidative stress and neuroinflammation in rat model of bilateral common carotid artery occlusion induced vascular dementia.
Bhatia P; Kaur G; Singh N
Vascul Pharmacol; 2021 Apr; 137():106827. PubMed ID: 33346090
[TBL] [Abstract][Full Text] [Related]
19. Ameliorative Effect of Phosphodiesterase-5 Inhibitor in Rat Model of Vascular Dementia.
Bhatia P; Singh N
Curr Neurovasc Res; 2019; 16(1):27-39. PubMed ID: 30706814
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia.
Jain S; Sharma B
Physiol Behav; 2015 Dec; 152(Pt A):182-93. PubMed ID: 26382939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
